| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $94.7M | $23.2M | $21.3M |
| YoY Revenue Growth % | +307.7% | +9.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$108.2M | -$83.3M | -$44.5M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$157.1M | -$85.7M | -$48.3M |
| EBITDA (Normalized) | -$107.2M | -$82.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$80.5M | -$46.1M | -$41.4M |
| Capital Expenditures (CapEx) | $1.2M | $425.0K | — |
| Free Cash Flow (FCF) | -$81.7M | -$46.6M | -$41.4M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $57.3M | $13.6M | — |
| Total Debt (Short + Long Term) | $29.5M | $67.0M | — |
| Total Stockholders' Equity | $135.2M | -$344.7M | — |